Zsolt Pápai-Székely

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

John V. Heymach, David H. Harpole, Tetsuya Mitsudomi et al. · New England Journal of Medicine · 2023 · 682 citations · Full text

Medicine, Oncology, Perioperative Medicine +17

FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

Donald E. Low, Thomas M. File, Paul B. Eckburg et al. · Journal of Antimicrobial Chemotherapy · 2011 · 185 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

International, Randomized, Placebo-Controlled, Double-Blind Phase III Study of Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer: MONET1

Giorgio V. Scagliotti, Ihor Vynnychenko, Keunchil Park et al. · Journal of Clinical Oncology · 2012 · 183 citations · Full text

Medicine, Oncology, Pharmacology +17

Talactoferrin alfa versus placebo in patients with refractory advanced non-small-cell lung cancer (FORTIS-M trial)

Suresh S. Ramalingam, Jeffrey Crawford, Alex Y. Chang et al. · Annals of Oncology · 2013 · 56 citations · Full text

Medicine, Oncology, Pharmacology +9

Current Practice of Airway Stenting in the Adult Population in Europe: A Survey of the European Association of Bronchology and Interventional Pulmonology (EABIP)

Hervé Dutau, David Breen, António Bugalho et al. · Respiration · 2017 · 34 citations · Full text

Medicine, Anesthesiology, General Internal Medicine +7